The issue with GGs post is that it missed the key point in latest update -- they may still apply for fast track designation when the time is right. After IND and perhaps on NDA
Simon nor any PR department is in a position to respond to every skidish shareholder. Delays see frustration and a correlating increase in queries.
PARs issues to date revolve around the moving goal posts in terms of how they plan to bring Ipps to market. This probably shows an element of inexperience but also flexibility. Read what PR initially planned to what they're now looking at achieving in TAM. Safety and durable trials will allow it the be easily prescribed by GPs and possibly self administered. If they pull it off your family and friends will all be quite envious
WANTED PARA-008 Trial Participants, page-105
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $78.73M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 21.5¢ | $288.5K | 1.279M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 130626 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |